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Fei Xiong
Investigating a Conformational 
Change in the Enzyme Neurolysin
  This summer I am working with Dr. 
David Rodgers in the Department of 
Molecular and Cellular Biochemistry at 
the University of Kentucky. I continue to 
investigate a proposed conformational change in the enzyme 
neurolysin, a zinc metallopeptidase that regulates peptide 
signaling molecules. My previous studies provided evidence 
that the enzyme undergoes a hinge-like motion during catalysis 
and demonstrated the ability of a novel inhibitor to interfere 
with that motion. I have expanded my work with neurolysin 
this summer using mutagenesis techniques to further 
investigate the conformational changes and the mechanism 
of inhibition. This gave me my first practical experience with 
molecular biology and genetics techniques. Dr. Rodgers and 
I have worked closely together for more than a year, and we 
discuss the project on a daily basis.
 My goal for this summer is to use  site-directed 
mutagenesis to alter the charge on the inner channel walls of 
the channel in neurolysin as well as to modify the binding 
site for the inhibitor C28. Since the channel walls have an 
overall negative surface charge, we hypothesize that increasing 
the charge will bias the enzyme toward an open conformation, 
which should reduce the activity of the enzyme. Furthermore, 
we hypothesize that C28 acts by inhibiting the hinge motion 
and that we can mimic this effect by using mutagenesis to fill 
the normal binding site of the inhibitor.
Progress
 To begin my work, Dr. Rodgers and I used the crystal 
structure of neurolysin to find modifiable sites on the protein 
so as to change the surface charge, settling on the mutation 
of lysine 221 and arginine 248 to glutamate residues.  We 
then designed oligonucleotide primers that could be used 
in site-directed mutagenesis to make the mutations and had 
the primers synthesized commercially. While waiting for 
the primers, I learned how to transform bacteria with the 
expression plasmid for neurolysin, and then I used a miniprep 
kit to make a stock of plasmid DNA. We then used the primers 
and plasmid DNA with the QuikChange mutagenesis system 
(Stratagene) to introduce the mutations by polymerase chain 
reaction (PCR) amplification. 
 We had a hard time making mutations on the wall surface 
of the enzyme at first. Because the mutagenesis protocol has 
been known to work properly, we had to sequentially eliminate 
possible causes of failure. The problem was eventually solved 
by repeating the protocol using freshly ordered reagents and 
by making fresh agar plates and media. Soon after solving the 
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buffer problem, we realized that something was amiss with 
the cell stock, possibly mutations or damage due to long term 
storage. Whatever it was, the cell stock was newly cultured 
and all problems have been overcome. We believe we have 
introduced the mutations successfully, and we are awaiting final 
sequencing conformation. In the meantime we are proceeding 
with attempts to overexpress and purify the mutant proteins, 
and we are designing primers to introduce the mutations at 
the C28 binding site.
Future Plans
 Assuming we have introduced the mutations correctly, 
we will then overexpress and purify the mutant enzymes 
according to well-established protocols in the group. The 
kinetic parameters of the wild type and mutant neurolysin 
constructs will then be determined by using fluorogenic 
peptide substrates (neurotensin and dynorphin A(1-8)). The 
conformational state of the mutant enzymes will also be 
determined by measuring rotational tumbling times using 
fluorescence polarization anisotropy measurements, and these 
will be compared to data for the wild type enzyme.
 In parallel, we will mutate serine 146, leucine 69, and 
valine 119 to tryptophan residues in order to fill the C28 
binding site. The idea is to increase the sizes of these amino 
acids to fill the C28 binding to mimic the inhibitor-bound 
state. We hypothesize C28 inhibits by stabilizing the open, 
inactive conformation of the enzyme and that filling the 
binding site should have the same effect. The expected result is 
that the mutated neurolysin would lose a significant amount 
of activity. I will also use fluorescence polarization to monitor 
the conformational changes of the altered enzymes and 
characterize the kinetic properties of the mutants on several 
substrates.
